All posts by imreal

Salesian Missions highlights social and educational programs that promote inclusion


News Image

“Salesian programs around the globe facilitate social and educational projects that pave the way for advanced research, learning and innovation that aid the inclusion of people with disabilities,” said Father Gus Baek, director of Salesian Missions.

INT’L DAY OF PEOPLE WITH DISABILITIES: Salesian Missions highlights social and educational programs that promote inclusion

Almost 1 billion people living with a disability, according to the World Health Organization.

Salesian Missions, the U.S. development arm of the Salesians of Don Bosco, joins humanitarian organizations and countries around the globe in honoring International Day of People with Disabilities. Since its inception in 1945, the United Nations has outlined and reiterated its commitment to calling for the creation of inclusive, accessible, and sustainable societies and communities.

In 1981, the U.N. proclaimed Dec. 3 as a recognized day for the celebration of the achievements of people living with disabilities across the world.

Almost 1 billion people, or 15 percent of the world’s population, are living with a disability, according to the World Health Organization (WHO) World Report on Disability. Nearly 250 million are living with a mental or neurological condition, and almost two-thirds of these people will not seek professional medical help, largely due to stigma, discrimination, and neglect.

This year’s theme “Transformative solutions for inclusive development: the role of innovation in fueling an accessible and equitable world” focuses on innovation for inclusive development in the areas of employment, reducing inequality, and sport as a practice example.

“Children living in poverty with a disability are even less likely to attend school and have the same opportunities as their peers,” said Father Gus Baek, director of Salesian Missions. “Salesian programs around the globe facilitate social and educational projects that pave the way for advanced research, learning and innovation that aid the inclusion of people with disabilities.”

Salesian Missions is proud to highlight Salesian programs that advance inclusivity for people with disabilities on International Day of People with Disabilities 2022.

EL SALVADOR

Don Bosco University in San Salvador, El Salvador, is empowering the next generation of medical rehabilitation practitioners to transform the lives of people with mobile disabilities through its “Walking Anew!” project. This project was made possible thanks to a grant from the U.S. Agency for International Development’s American Schools and Hospitals Abroad (USAID/ASHA) program secured by Salesian Missions.

The project expanded and upgraded the facilities at Don Bosco University’s School of Rehabilitation Science and the equipment used to train medical rehabilitation professionals. Completed in June 2022, it is revolutionizing the field of rehabilitation science across Latin America with a new laboratory and research annex, modern technology, and extending the reach of Don Bosco University School of Rehabilitation Science through an expanded distance learning program.

The construction of the new building, which houses the Applied Research Center, allows for the exchange of information with professionals in the field at an international level as well as provides space for a new podiatry laboratory and other specialized practices.

The program has already trained people from El Salvador, other countries in Central America, South America, Haiti, Angola and the Democratic Republic of the Congo. In 2022, the project was also able to train students in Uganda through the distance learning program.

INDIA

Don Bosco Job Placement Network in India, through collaboration with Bangalore Rural Education and Development Society (BREADS), organized a job fair for employment seekers with disabilities. Working with Samarthanam Trust for the Disabled, Don Bosco Job Placement Network held the job fair at Bell Hotel Majestic for more than 100 candidates with varying levels of ability.

At the job fair, Quess Corp. Pvt. Ltd. Bangalore recruited candidates for jobs in warehousing, business process outsourcing and e-commerce, and logistics (packing and billing). The Don Bosco Job Placement Network coordinator and the Quess team assisted the candidates in career counseling and by explaining the job roles. Of nearly 40 candidates who applied for the various jobs, 12 received immediate offers and others were shortlisted for future placement.

The Don Bosco Job Placement Network aims to improve employment opportunities for underserved job seekers through career guidance and skills training. The organization also enables access to secure job markets through job referral services, ensuring retention, and improving quality job opportunities with adequate wages and decent, safe, and secure working conditions.

MEXICO

People living with spinal cord injuries will have a new treatment center thanks to funding Salesian Missions received from USAID’s ASHA program for the “Raising Standards of Care for Spinal Cord Injury Patients” project. The project will construct and equip Mexico’s first comprehensive treatment and rehabilitation center to assist patients who have been paralyzed by spinal cord injuries, with a special focus on youth.

The project runs from October 2018 through the end of September 2023. Construction is currently underway. The Latin American Center for the Treatment of Spinal Cord Injuries, which will be built in Guadalajara, will be the only center in Mexico dedicated to serving the target population.

The treatment center aims to promote the American values of equal access and opportunity by empowering young people with spinal cord injuries with the physical independence and renewed self-esteem needed to actively participate in society.

The state-of-the-art treatment and rehabilitation center will be equipped with cutting-edge technology and innovative resources. In addition to treating patients, the center will also generate and disseminate new science and technology. Within its first four years, it is anticipated that the center will treat 500 patients with spinal cord injuries, mainly youth and young adults between the ages of 12-35 who live in poverty and in a state of high vulnerability.

SPAIN

Cadiz Virgili Don Bosco, a five-a-side soccer club founded at the Don Bosco Institute in Cadiz, Spain, expanded its sports-educational offerings with a team dedicated to people with disabilities known as the Eyser team. The team launched in 2021. Training for team members takes place free of charge on Mondays and Wednesdays at the Don Bosco Institute.

The team’s name honors George Eyser, the first Olympic athlete with a disability, who won six medals as a gymnast. The Eyser team was an initiative of the Don Bosco team’s coaches, Teresa Atero and Néstor Villegas, and has received the support of the Don Bosco Polideportivo Club and of the five-a-side soccer team Cadiz Virgili Futsal.

Cadiz Virgili Don Bosco currently has several teams engaged in tournaments and training. The teams are run by qualified and certified coaches who, with the support of the Salesian community, promote the individual care and development of athletes.

Salesian Father Rafael Cazorla, coordinator of the Salesian sports club, added, “We want to achieve greater integration in sport. It is very important to work in this direction and that is why we want this team to continue to grow and be able to compete in tournaments in the near future.”

###

About Salesian Missions USA

Salesian Missions is headquartered in New Rochelle, NY, and is part of the Don Bosco Network—a worldwide federation of Salesian NGOs. The mission of the U.S.-based nonprofit Catholic organization is to raise funds for international programs that serve youth and families in poor communities around the globe. The Salesian missionaries are made up of priests, brothers and sisters, as well as laypeople—all dedicated to caring for poor children throughout the world in more than 130 countries and helping young people become self-sufficient by learning a trade that will help them gain employment. To date, more than 3 million youth have received services funded by Salesian Missions. These services and programs are provided to children regardless of race or religion. For more information, go to SalesianMissions.org.

Contact:

Hannah Gregory

media@salesianmissions.org

914-960-4642 (text messages OK)

Twitter: @MissionNewswire

Newswire: MissionNewswire.org

Press room: SalesianMissions.org/press



AUO Display Plus Presents Full Range of 3D Medical Imaging Solutions at the Healthcare+ Expo Taiwan 2022


News Image

ADP Smart Dental Shade Matching Solution, providing a one-stop accurate colorimetric solution for three critical procedures of image capture, algorithm, and display during denture production.

AUO Display Plus (ADP) will participate in the Taiwan Healthcare+ Expo from December 1-4, 2022, with the theme “Creating Unlimited Possibilities for Smart Healthcare”. ADP will join ADLINK, Cypress Technology, MedicalTek, IADEA, imedtac, Quanta, and others in exhibiting innovative medical products and solutions for 3D medical imaging, smart surgery, examination and diagnosis, and telemedicine.

Utilizing 3D and A.R.T. display technologies in four major areas

ADP leverages its core 3D and A.R.T. display technologies and closely cooperates with ecosystem partners to launch software and hardware integration solutions, including 3D medical imaging, operating room dashboard, eye care for radiology image analysis, dental shade matching, and Care Pod. The 3D medical imaging zone will display the full-process 3D imaging solutions, demonstrating the multiple applications of ADP’s leading display technologies in full 3D surgical applications.

“Technological progress has brought new waves of digital transformation and applications to healthcare, particularly telemedicine and precision medicine.” said Shih-Hong Liao, President of ADP. “Every ADP solution starts with analyzing the pain points of hospitals and medical personnel. ADP leverages its strength and achievements in high-quality medical imaging displays and software and hardware integration. We work with ecosystem partners to provide high-precision, high-efficiency, and highly-integrated solutions to assist hospitals in improving medical quality and patient experience. As we advance, ADP continues to use its leading display technologies, and diverse product portfolio and solutions in its commitment to address the unmet needs in Taiwan’s medical field. We look forward to exploring new business niches for local and international cooperation through this exhibition.”

3D Medical Imaging: Opening new horizons with 4K 3D imaging for perioperative phases

ADP extends its advantages in 3D display technologies, developing 3D image display systems and solutions for before, during, and after surgery, providing doctors with ultra-clear 3D images to help improve the precision and safety of surgery.

  • Immersive Display System for Preoperative Planning is developed explicitly for preoperative planning in precision microsurgery. The 4K glasses-free 3D medical display can display high-definition 3D images and quickly switch between 2D and 3D images through a humanized design that helps surgeons to clearly identify nerves and blood vessels, precisely plan the surgical path, and accurately evaluate the expected outcomes before the surgery, thereby increasing the accuracy and success rate of the surgery.
  • Heads-up 3D Imaging Display System for Microsurgery integrates a 4K glasses-free 3D display and an eye-tracking system, which can quickly track the position of the human eye. It can reduce the burden of the doctor to maintain a fixed posture for a long time, freeing the doctor from the fixed eyepiece of a traditional microscope and allowing the doctor to have a wider and clearer 3D stereoscopic image and a more comfortable position.
  • 3D Imaging Solution for Remote Surgical Training supports the conversion of 2D images into 3D, 3D imaging streaming for robotic surgery, or the real-time streaming of 3D images for 3D minimally invasive surgeries. Other doctors or students viewing remotely can see the same 3D stereoscopic images as the surgical team and experience the immersive visual effects of the surgical scene. Whether for intra- or post-operative surgical demonstration, or distance teaching and training, this solution can shorten the surgical learning curve, reduce communication costs, and ensure the quality of surgical teaching.

Smart Surgery: Consolidating medical images and information to optimize surgical procedures

  • Smart Operating Room Dashboard Solution provides an intuitive, multi-functional operation interface and platform, consolidating patient physiological information and surgical process images into a single dashboard, allowing medical staff to quickly obtain the required information, making the surgical process smoother, and reducing risk during the surgery.
  • A.R.T. Non-glare OR Medical Monitor uses A.R.T. advanced anti-reflection technology to reduce reflections from lights in the operating room, allowing surgeons to view clear, high-quality 4K surgical images from any angle, reducing eye fatigue caused by watching the screen for a long time, and helping improve surgical efficiency.

Examination and Diagnosis: Ushering in a new era of medical image interpretation with A.R.T. display technology

  • Eye Care Solution for Radiology Image Analysis combines A.R.T. eye protection displays and Quanta’s intelligent chest X-ray AI system, taking into account comfortable eye protection and accurate diagnosis. The A.R.T. technology complies with TÜV Rheinland non-reflection standard. Hence, doctors no longer need to perform diagnostic work in dark environments. The intelligent chest X-ray system uses AI technology to quickly screen for major diseases assist in image-assisted interpretation, and can generate automatic auxiliary reports, effectively improving the diagnostic accuracy and work efficiency of doctors.
  • Smart Dental Shade Matching Solution provides a one-stop accurate colorimetric solution for the three critical procedures of image capture, algorithm, and display during the production of dentures. Through cloud-based color algorithm software and A.R.T. displays, the true color of dental images can be restored even in cross-platform operations, improving the accuracy of dental image transmission and display between dental clinics and dental laboratories. The optimization of the colorimetric process and accurate colorimetric management reduce the communication cost and reproduction ratio of denture production.

Telemedicine: Breaking down time and space constraints through multi-functional integration and instant doctor-patient communication

  • Care Pod is an innovative and integrated solution launched by ADP in response to the trends of medical digitization and aging society, providing an innovative integrated solution to meet the increasing demands for remote consultation for follow-up, chronic patients, and more. This multi-function, high-privacy Care Pod can provide flexible and customized functions for the different needs of patients and physicians, making it possible to have in-person checkups at a distance, saving the energy and time of doctors and patients. The patient-side application integrates physiological measurement instruments and mobile medical carts, and uploads patients’ physiological measurement data to the cloud remote diagnosis and treatment platform in real-time. The doctor-side application integrates ADP’s newly launched Digital Health Switch, which receives the physiological data and measured values through the cloud-based remote diagnosis and treatment platform. allowing doctors to conduct remote video and consultation with patients through a convenient visual operation interface. The Care Pod includes Totem Plus intelligent disinfection equipment, which has network connection and remote monitoring functions, and can provide instant reminders of disinfectant replenishment.
  • Digital Health Switch combines a high-resolution touchscreen, camera, and microphone to support dual-system operation and connect internal and external networks of the hospital to achieve data consistency and account information security. Digital Health Switch has a variety of convenient tools for daily use by medical staff, including digital sign-off and touchscreen writing, facilitating better doctor-patient communication, making medical work easier, and creating a more complete digital medical facility.

ADP inherits AUO’s core display technology, actively deploys smart healthcare solutions, integrates technologies such as AIoT and edge computing, and works with partners to develop highly integrated solutions that increase accuracy, improve efficiency, and promote doctor-patient relationships, creating new value for hospitals and medical professionals through the fusion of technology and healthcare. ADP will continue to form complementary, collaborative, and co-creative alliances with partners in the healthcare ecosystem to create infinite possibilities for smart healthcare.

AUO photos can be downloaded at the Company’s website: https://auo.com/en-global/Download_Photos

Any use of photographs must cite the source thereof as AUO Corporation.

Share article on social media or email:

First Human Clinical Trial Proves TruZen® CBD Formula with Patented VESIsorb® Technology Achieves 360% greater Bioavailability of β-caryophyllene (BCP)


TruZen®  CBD

TruZen® CBD

We are very excited by the results of this first ever human-based clinical trial, validating our proprietary TruZen® formula with VESIsorb®’s superior potency and absorbency of β-caryophyllene (BCP).

Nutraceuticals Innovator TruZen® Health has announced the results of a first ever human-based clinical trial, proving its proprietary TruZen® CBD formula with patented VESIsorb® Technology achieves 360% greater bioavailability of β-caryophyllene (BCP).

BCP is a natural bicyclic sesquiterpene and a common constituent of the essential oils of numerous food plants such as hemp (Cannabis sativa L) and is thought to interact with the endocannabinoid system by binding selectively to cannabinoid receptors type 2 (CB2). Decades of preclinical research have investigated the potential therapeutic benefits of BCP, such as analgesic, anti-inflammatory, and anti-depressive.

The clinical trial, a randomized, double-blind, cross-over design, single oral dose study1 [100 mg β-caryophyllene (BCP)] in 24 healthy subjects (12 men/12 women) was performed under fasted conditions and evaluated the relative bioavailability of BCP formulated with VESIsorb® to that of the same BCP neat oil. In addition to the superior PK results of the BCP VESIsorb® formulation, there are significant findings that highlight the scientific and medical contributions from this new study.


  • This is the first published study to demonstrate safe and well-tolerated BCP doses as high as 100 mg, a 10x increase compared to the natural daily human exposure
  • This is the first published study to demonstrate that BCP has poor bioavailability in humans
  • This is the first published study to reveal there is no significant difference between men and women for both investigated formulations and all investigated PK endpoints

The new clinical trial was conducted by Geocann®, a global cannabis organization that combines clinically researched cannabinoids and terpenes with technologically advanced drug delivery system technologies that increase absorption and bioavailability for maximum health benefits.

Reference more on the new human clinical trial here: https://www.mdpi.com/1420-3049/27/9/2860

Widely regarded as today’s best-in-class CBD product produced under the highest ethical and quality standards, TruZen® has also been validated as a superior CBD product in a previously published Clinical Trial Study: “A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects.”

Unlike typical CBD products, TruZen® CBD delivers a lipid-based, natural, hemp oil product to be delivered in a water-soluble form with no loss in bio-efficacy or absorption. Its patented VESIsorb® delivery system has been proven in previously conducted human clinical trials to increase absorption by mor than 400 times other CBD products. TruZen® CBD softgels disperse uniformly, transferring the CBD bioactives directly to the intestinal lymphatic system for boosted bioavailability and faster results. Benefits start in 90 seconds, and users will feel the full effect within 30 to 60 minutes. TruZen® CBD is 4.4 times more bioavailable than the leading CBD brand made with MCT oil. Tests show that the human body needs only 25 mg of TruZen® CBD to their 100 mg.

According to TruZen® Health VP Operations and Co-Founder, Michael Lioon, “we are very excited by the results of this first ever human-based clinical trial, validating our proprietary TruZen® formula with VESIsorb®’s superior potency and absorbency of β-caryophyllene (BCP). Our commitment to providing the highest quality, clinically proven products is stronger than ever today.”

TruZen® CBD is manufactured by TruZen® Health, continuing its legacy of three family generations and 70 years of nutraceutical experience, with products produced under the highest ethical standards. TruZen® CBD is the first product it has ever offered directly to consumers.

TruZen® Health is offering all new customers an introductory 10-Day trial of TruZen® CBD. To learn more, please visit https://www.truzenhealth.com/10-day-trial-special/.

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

###

Share article on social media or email:

Study by RIT scientists indicates SARS-CoV-2 variants are still transmissible between species


bats of genus Rhinolophus

RIT scientists studied how the viral spike proteins in several SARS-CoV-2 variants interact with the host cell receptors known as ACE2 in both humans and bats. Shutterstock.

“We were hoping to see really cool adaptive evolution happening as the virus got more used to humans and less used to bats, but we actually saw that there wasn’t a whole lot of change.” – Associate Professor Gregory Babbitt, RIT

Scientists believe bats first transmitted SARS-CoV-2 to humans in December 2019, and while the virus has since evolved into several variants such as delta and omicron, a new study indicates the virus is still highly transmissible between mammals. Researchers at Rochester Institute of Technology developed computer simulations that show the coronaviruses use their spike proteins to attach themselves to the host cells in both bats and humans in much the same way.

The findings were published in a Royal Society Open Science study by recent RIT alumnus Madhusudan Rajendran ’22 MS (bioinformatics) and Associate Professor Gregory Babbitt from the Thomas H. Gosnell School of Life Sciences. They studied how the viral spike proteins in several SARS-CoV-2 variants interact with the host cell receptors known as ACE2 in both humans and various bats of genus Rhinolophus. Babbitt said the results were surprising.

“We were hoping to see really cool adaptive evolution happening as the virus got more used to humans and less used to bats, but we actually saw that there wasn’t a whole lot of change,” said Babbitt. “Because this binding site has not evolved very much, there’s really not much stopping it from transmitting from humans to bats. If you look at the phylogenetic relationships of bats to humans, we’re pretty far apart on the mammalian tree. So it suggests that there would be pretty widespread cross-species infectivity, and the literature has shown there’s been a lot of evidence of that.”

The scientists used a computer simulation method called molecular dynamics to put proteins in a solvated simulation and then watch them move. The approach uses high performance computing on graphics processors to show what every atom does over time. Babbitt said this approach allows scientists to study questions that cannot be answered in a traditional laboratory.

“It would be dangerous to do experiments where we reinfected bats with human viral strains, so our computer-based simulations offered a much safer alternative,” said Babbitt.

To read the full study, go to the Royal Society website.

Share article on social media or email:

‘Tis the Season for Giving Back at Jim Ellis Automotive


News Image

We are deeply grateful for the support of the Jim Ellis family. They have been generous, long-time supporters of Children’s Healthcare of Atlanta.

The Jim Ellis Automotive Group is pleased to announce their seventh annual holiday giving campaign supporting Children’s Healthcare of Atlanta. Starting December 1, 2022 through December 31, 2022, each of the 20 Jim Ellis family-owned and operated dealerships will donate a portion of every sale of all new or pre-owned vehicles to The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta.,

Each year, the Jim Ellis Automotive Group selects a different local charity to support with the company’s holiday giving campaign, selecting the Aflac Cancer and Blood Disorders Center of Children’s as the recipient for 2022. Through their efforts over all of the holiday giving campaigns, Jim Ellis Automotive has donated over $250,000 to groups supporting women and children in need across the Atlanta area. Last year’s campaign raised $68,850 to benefit the Atlanta Children’s Shelter and this year it is expected to raise at least $65,000 to support those facing pediatric cancer.

The Jim Ellis Automotive Group is a long-time supporter of the Aflac Cancer and Blood Disorders Center of Children’s, donating a portion of the funds from the Annual Jim Ellis Charity Golf Tournament to this cause each year for at least the last 10 years.

“We are deeply grateful for the support of the Jim Ellis family,” said Janine Musholt, president of the Children’s Healthcare of Atlanta Foundation. “They have been generous, long-time supporters of Children’s Healthcare of Atlanta. We are humbled by their ongoing desire to collaborate with us to care for Georgia families.”

“No one wants to see a child struggle or be in pain” said Jim Ellis Automotive Group Vice President Stacey Ellis Hodges. “We hope that our donation this holiday season can bring a little extra joy to a child and their family at a time when they need support most. We can give a child the gift of growing up, together.”

About Jim Ellis Automotive Group

Jim Ellis Automotive Group has been serving the Atlanta area since 1971, starting with Volkswagen as the flagship brand. The group has expanded to 17 brands and 20 dealerships, covering Atlanta, Buford, Kennesaw, McDonough, Marietta, Sandy Springs and South Fulton. Brands include Alfa Romeo, Audi, Buick, Cadillac, Chevrolet, Ford, GMC, Genesis, Hyundai, Kia, Maserati, Mazda, Mercedes, Porsche, Toyota, Volkswagen and Volvo. Visit our stores or shop from the comfort of your home at jimellis.com.

About Children’s Healthcare of Atlanta

As the only freestanding pediatric healthcare system in Georgia, Children’s Healthcare of Atlanta is the trusted leader in caring for kids. The not-for-profit organization’s mission is to make kids better today and healthier tomorrow through more than 60 pediatric specialties and programs, top healthcare professionals, and leading research and technology. Children’s is one of the largest pediatric clinical care providers in the country, managing more than one million patient visits annually at three hospitals, Marcus Autism Center, the Center for Advanced Pediatrics, urgent care centers and neighborhood locations. Consistently ranked among the top children’s hospitals by U.S. News & World Report, Children’s Healthcare of Atlanta has impacted the lives of kids in Georgia, across the United States and around the world for more than 100 years thanks to generous support from the community.

###

Share article on social media or email: